Walgreens Boots Alliance Announces Transfer of Listing of Debt Securities to Nasdaq
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it will be transferring the securities exchange listing for its 2.125% Senior Notes due 2026, 2.875% Senior Notes due 2020 and 3.600% Senior Notes due 2025 from the New York Stock Exchange to the Nasdaq Bond Exchange effective December 21, 2018 after market close. The debt securities are expected to begin trading on the Nasdaq Bond Exchange on December 24, 2018. The respective trading symbols and CUSIP numbers of the debt securities are listed below.
|Series of Debt Securities||Trading Symbol||CUSIP|
|2.125% Senior Notes due 2026||WBA /26||931427AJ7|
|2.875% Senior Notes due 2020||WBA /20||931427AK4|
|3.600% Senior Notes due 2025||WBA /25||931427AL2|
Walgreens Boots Alliance is transferring the listing of these debt securities to Nasdaq to consolidate its equity and debt listings relationships under one exchange.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise. The company's heritage of trusted health care services through community pharmacy care and pharmaceutical wholesaling dates back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25 countries and employ more than 415,000 people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with its equity method investments, has more than 18,500 stores in 11 countries as well as one of the largest global pharmaceutical wholesale and distribution networks, with more than 390 distribution centers delivering to more than 230,000 pharmacies, doctors, health centers and hospitals each year in more than 20 countries. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.
Walgreens Boots Alliance is proud to be a force for good, leveraging many decades of experience and its international scale, to care for people and the planet through numerous social responsibility and sustainability initiatives that have an impact on the health and wellbeing of millions of people.
More company information is available at www.walgreensbootsalliance.com.
Cautionary Note Regarding Forward-Looking Statements: All statements in this release that are not historical are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated, including, but not limited to, those described in Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended August 31, 2018 and in other documents that we file or furnish with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, we do not undertake, and expressly disclaim, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181211005854/en/